Report overview
Bispecific antibodies can simultaneously address two different antigens, which are sufficient to target two trails involved in cancer pathogenesis, and therefore, provide advantages over monoclonal antibodies therapy.
This report contains market size and forecasts of Bispecific Antibodies for Cancer in global, including the following market information:
Global Bispecific Antibodies for Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bispecific Antibodies for Cancer Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Bispecific Antibodies for Cancer companies in 2021 (%)
The global Bispecific Antibodies for Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CD19/CD3 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bispecific Antibodies for Cancer include Amgen, Astella Pharma, Ben Kang Biopharmaceutical (Shenzhen), Merus and Regeneron Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Bispecific Antibodies for Cancer manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bispecific Antibodies for Cancer Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bispecific Antibodies for Cancer Market Segment Percentages, by Type, 2021 (%)
CD19/CD3
CD30/CD16A
Global Bispecific Antibodies for Cancer Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bispecific Antibodies for Cancer Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmaceutical Companies
Other
Global Bispecific Antibodies for Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bispecific Antibodies for Cancer Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bispecific Antibodies for Cancer revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bispecific Antibodies for Cancer revenues share in global market, 2021 (%)
Key companies Bispecific Antibodies for Cancer sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Bispecific Antibodies for Cancer sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Astella Pharma
Ben Kang Biopharmaceutical (Shenzhen)
Merus
Regeneron Pharmaceuticals
